Nuclear factor-kappa B and its role in inflammatory lung disease

Area of Science:

• Molecular Biology
• Immunology
• Respiratory Medicine

Background:

• Nuclear factor-kappa B (NF-κB) is a crucial dimeric transcription factor regulating inflammation and immune responses.
• Inflammation is central to numerous respiratory conditions, including asthma, COPD, and acute respiratory distress syndrome.
• NF-κB signaling involves the Rel protein family, with five members producing transcriptionally active molecules.

Purpose of the Study:

• To elucidate the role of NF-κB in various respiratory disorders.
• To highlight NF-κB as a significant factor in inflammatory lung diseases.
• To identify NF-κB as a potential therapeutic target for drug development.

Main Methods:

• Review of literature on NF-κB signaling pathways.
• Analysis of NF-κB involvement in the pathogenesis of respiratory diseases.
• Identification of stimuli triggering NF-κB activation.

Main Results:

• NF-κB activation is stimulated by a wide range of factors including cytokines, microbial components, and stress.
• NF-κB is implicated in the pathophysiology of asthma, COPD, lung cancer, and infectious diseases like pneumonia and COVID-19.
• NF-κB is a principal component in the development of inflammatory lung diseases.

Conclusions:

• NF-κB is a critical regulator of inflammatory and immune processes relevant to respiratory health.
• Targeting NF-κB presents a promising strategy for therapeutic interventions in respiratory diseases.
• Further research into NF-κB pathways could lead to novel drug development for conditions like COVID-19.